XTL BIOPHARMA. ADR 100 |
USA |
Gesundheit |
US98386D3070 / A2DK34 |
H2K2 (Frankfurt) / XTLB (NASDAQ) |
FRA:H2K2, ETR:H2K2, H2K2:GR, NASDAQ:XTLB |
- |
http://www.xtlbio.com |
8.54 Mio. EUR |
0.39 Mio. EUR |
-1.71 Mio. EUR |
-0.225 EUR |
0.12 Mio. EUR |
0.99 Mio. EUR |
- / - |
4.54 / - |
15.76 / 1.64 / - |
-227.72% / -26.83% |
- |
- / - |
- |
XTL BIOPHARMACEUTICALS, XTL BIO, XTL BIOPHARMA |
06.07.25 |
|